Small cell carcinoma of the ovary Advocacy Hub | UniteRare

At a Glance

Live from database

💊

Regulatory Watchboard

10 events

Mar 2026Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

Conjupro Biotherapeutics, Inc. — PHASE1

TrialRECRUITING

Dec 2025Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Whitehawk Therapeutics, Inc. — PHASE1

TrialRECRUITING

Dec 2025Minimal Residual Disease in Solid Malignancies

European Institute of Oncology — NA

TrialNOT YET RECRUITING

Jan 2025Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib

AstraZeneca — PHASE1

TrialNOT YET RECRUITING

Jan 2025A Phase 1 Study of LNCB74 in Advanced Solid Tumors

NextCure, Inc. — PHASE1

TrialRECRUITING

Sep 2024A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors

Heronova Pharmaceuticals — PHASE1, PHASE2

TrialRECRUITING

May 2024Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

National Cancer Institute (NCI) — PHASE1

TrialACTIVE NOT RECRUITING

Nov 2023A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

Seagen, a wholly owned subsidiary of Pfizer — PHASE2

TrialACTIVE NOT RECRUITING

Jan 2022A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

Ascendis Pharma Oncology Division A/S — PHASE1, PHASE2

TrialACTIVE NOT RECRUITING

Dec 2021GEN1047 for Solid Tumors - First in Human (FIH) Trial

Genmab — PHASE1, PHASE2

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

2 programs

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance1

Oncoscint CR/OV

Cytogen Corporation

OpenContact for details

Patient Assistance Programs1

Taxol

Bristol-Myers Squibb Pharmaceutical Research Institute

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

2 FDA-approved

Oncoscint CR/OV

(Satumomab pendetide)Orphan drug

Cytogen Corporation

Approved Dec 1992

Taxol

(Paclitaxel)Orphan drugstandard

Bristol-Myers Squibb Pharmaceutical Research Institute

Microtubule Inhibitor [EPC]

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

8 active trials

1Phase 2

5Phase 1

2PHASE1, PHASE2

8Total recruiting

Search clinical trials for Small cell carcinoma of the ovary →

Recent News & Research

No recent news articles indexed yet for Small cell carcinoma of the ovary.
Search PubMed for Small cell carcinoma of the ovary →

Browse all Small cell carcinoma of the ovary news →

Specialist Network

Top 6 by expertise

Study Official

Genmab

Score 99 trials

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Score 819 trials

Willis Navarro, MD, M.D

University of California, San Francisco

📍 TUCSON, AZ

Score 84 trials

Susan K. Parsons, MD, MRP

Tufts Medical Center Cancer Center

Score 61 trial

Paul Martin

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Score 63 trials73 pubs

Glen Liu, M.D

University of Wisconsin, Madison

Score 51 trial

View all Small cell carcinoma of the ovary specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰